Jump to content

Minitran

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 16:17, 27 September 2023 (Removed parameters. | Use this bot. Report bugs. | #UCB_CommandLine). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Minitran is a commercial psychiatric drug (tranquilliser and antidepressant) manufactured in Greece by Adelco S.A. and sold in form of yellow-coloured sugar-coated tablets.[1]

It contains Amitriptyline hydrochloride and Perphenazine.

It is sold in the following forms:

  • Minitran 2-10: 2 mg Perphenazine and 10 mg Amitriptyline hydrochloride in each tablet.
  • Minitran 2-25: 2 mg Perphenazine and 25 mg Amitriptyline hydrochloride in each tablet.
  • Minitran 4-10: 4 mg Perphenazine and 10 mg Amitriptyline hydrochloride in each tablet.
  • Minitran 4-25: 4 mg Perphenazine and 25 mg Amitriptyline hydrochloride in each tablet.

Minitran is also a pharmaceutical drug for the treatment of Angina, manufactured by 3M.

It contains glyceryl trinitrate and is sold in patch form. It is sold in the following strengths:

  • Minitran 5 contains 18 mg of glyceryl trinitrate and delivers 5 mg in 24 hours
  • Minitran 10: contains 36 mg of glyceryl trinitrate and delivers 10 mg in 24 hours
  • Minitran 15: contains 54 mg of glyceryl trinitrate and delivers 15 mg in 24 hours

It is also marketed as Discotrine in some countries.

See also

References

  1. ^ "Minitran". US GOV.